Huntington's disease (HD) is a fatal neurodegenerative disease characterized by metabolic, cognitive, and motor deficits. HD is caused by an expanded CAG repeat in the first exon of the HTT gene, resulting in an expanded polyglutamine section. Dietary restriction (DR) increases lifespan and ameliorates age-related pathologies, including in a model of HD, but the mechanisms mediating these protective effects are unknown. We report metabolic and behavioral effects of DR in the full-length YAC128 HD mouse model, and associated transcriptional changes in hypothalamus and striatum. DR corrected many effects of the transgene including increased body weight, decreased blood glucose, and impaired motor function. These changes were associated with reduced striatal human (but not mouse) HTT expression, as well as alteration in gene expression regulating histone acetylation modifications, particularly Hdac2. Other mRNAs related to Huntington's pathology in striatal tissue showed significant modulation by the transgene, dietary restriction or both. These results establish a protective role of DR in a transgenic model that contains the complete human HTT gene and for the first time suggest a role for DR in lowering HTT level, which correlates with severity of symptoms.
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Introduction
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease characterized by chorea, cognitive deficits, and mood disorders (Walker, 2007) . HD is caused by extended CAG repeats in exon 1 of the huntingtin gene (HTT) resulting in an expanded polyglutamine (polyQ) region at the N-terminus. This mutation impacts disease prognosis and penetrance according to the number of repeats with full penetrance beyond 41 repeats (Duyao et al., 1993; Langbehn et al., 2004; McNeil et al., 1997; Rubinsztein et al., 1996) . Disease severity further correlates with level of mutant protein in human patients and mouse models (Graham et al., 2006; Hodgson et al., 1999; Squitieri et al., 2003) . Prominent neuropathology in HD patients includes the loss of striatal medium spiny neurons (Bruyn et al., 1979; Graveland et al., 1985) , as well as loss of cortical neurons (Cudkowicz and Kowall, 1990; Hedreen et al., 1991) . In addition, abnormalities in the hypothalamus may contribute to metabolic and other defects, e.g. hyperglycemia and disruption of circadian rhythms (Hult et al., 2011; Hurlbert et al., 1999; Morton et al., 2005; Petersén and Björkqvist, 2006) .
In HD, there is considerable neuronal dysfunction leading to symptoms and ultimately neurodegeneration prior to death. A previous study in an HD fragment model using a prion promoter driven transgene, i.e. HD-N171-82Q, demonstrated later onset of symptoms and extended lifespan in animals subjected to dietary restriction (DR) (Duan et al., 2003) . The present studies examined if DR would mitigate the phenotype in a full-length mouse model of HD. In addition, expanded polyglutamine impacts transcriptional regulation, in part by sequestering transcriptional machinery (Cui et al., 2006; Dunah et al., 2002; Nucifora et al., 2001a) , and these transcriptional changes in the context
